rs3074455
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001846.4(COL4A2):c.*101_*102del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.57 in 1,349,882 control chromosomes in the GnomAD database, including 202,731 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.55 ( 22851 hom., cov: 0)
Exomes 𝑓: 0.57 ( 179880 hom. )
Consequence
COL4A2
NM_001846.4 3_prime_UTR
NM_001846.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.271
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 13-110512281-TAA-T is Benign according to our data. Variant chr13-110512281-TAA-T is described in ClinVar as [Benign]. Clinvar id is 311201.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.571 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL4A2 | NM_001846.4 | c.*101_*102del | 3_prime_UTR_variant | 48/48 | ENST00000360467.7 | NP_001837.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL4A2 | ENST00000360467.7 | c.*101_*102del | 3_prime_UTR_variant | 48/48 | 5 | NM_001846.4 | ENSP00000353654 | P1 | ||
COL4A2 | ENST00000648222.1 | n.928_929del | non_coding_transcript_exon_variant | 1/1 | ||||||
COL4A2 | ENST00000650225.1 | n.2895_2896del | non_coding_transcript_exon_variant | 19/19 |
Frequencies
GnomAD3 genomes AF: 0.553 AC: 82697AN: 149576Hom.: 22831 Cov.: 0
GnomAD3 genomes
AF:
AC:
82697
AN:
149576
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.572 AC: 686056AN: 1200200Hom.: 179880 AF XY: 0.569 AC XY: 333320AN XY: 585618
GnomAD4 exome
AF:
AC:
686056
AN:
1200200
Hom.:
AF XY:
AC XY:
333320
AN XY:
585618
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.553 AC: 82763AN: 149682Hom.: 22851 Cov.: 0 AF XY: 0.546 AC XY: 39869AN XY: 72960
GnomAD4 genome
AF:
AC:
82763
AN:
149682
Hom.:
Cov.:
0
AF XY:
AC XY:
39869
AN XY:
72960
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Porencephalic cyst Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 02, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at